| Hans-Günter Meyer-Thompson | Buprenorphin
USA. National Institute on Drug Abuse Funds New Adherence Technology for Opioid Addiction
emocha Mobile Health has been awarded funding by NIDA to study and commercialize adherence technology for people with opioid addiction. In partnership with the University of Washington and Boston Medical Center, emocha will assess patients on office-based buprenorphine treatment using video direct observation. (prweb.com, USA, 21.06.2017)